Condition: Facioscapulohumeral Muscular Dystrophy · FSHD · FSHD - Facioscapulohumeral Muscular Dystrophy · Sponsor: Avidity Biosciences, Inc.
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
This description comes directly from the study's public registry record.
Avidity Biosciences, Inc., A Novartis Company · 1-888-669-6682 · novartis.email@novartis.com
Avidity Biosciences, Inc., A Novartis Company · +41613241111 · novartis.email@novartis.com
Always discuss trial participation with your own doctor first.
| University of California Irvine | Orange, California, United States | Active Not Recruiting |
| Stanford University | Palo Alto, California, United States | Active Not Recruiting |
| University of Colorado | Denver, Colorado, United States | Active Not Recruiting |
| University of Florida | Gainesville, Florida, United States | Active Not Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Active Not Recruiting |
| Kansas University Medical Center | Kansas City, Kansas, United States | Active Not Recruiting |
| Kennedy Krieger Institute | Baltimore, Maryland, United States | Active Not Recruiting |
| University of Massachusetts | Worcester, Massachusetts, United States | Active Not Recruiting |
| University of Rochester Medical Center | Rochester, New York, United States | Active Not Recruiting |
| Duke University | Durham, North Carolina, United States | Active Not Recruiting |
| Ohio State University | Columbus, Ohio, United States | Active Not Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Active Not Recruiting |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07038200